Fibristal (ulipristal Acetate Tablets, 5 Mg) - Voluntary Withdrawal In Canada Due To Risk Of Drug-induced Liver Injury

Fibristal Recall Summary Fibristal (ulipristal acetate 5 mg tablets) is being voluntarily withdrawn from the Canadian market due to a risk of drug-induced liver injury. This medication was distributed across Canada. The recall affects anyone who currently has or is using this product.

Reason

Product safety

Category

drug recall

Country

Canada

Agency

HC-DRUGS

Recall date

2020-09-30

Status

Ongoing

Distribution

Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/c82160e0-062e-4ae6-ae6d-081b502c740a